Jabra Enhance Pro 20 at Costco vs Resound Vivia 9 60S microRIE

The Jabra Enhance Pro 20 at Costco is a prescription behind-the-ear hearing aid available for $1,600, earning an A grade with a SoundScore of 4.0/5 in our lab testing. This places it in the top 61% of the 36 prescription hearing aids we've evaluated. In our testing, this device shows a mixed performance profile. Own-voice comfort is a clear strength, scoring 3.5/5—0.75 points above the category average—making it a solid choice for users who prioritize natural sound quality when speaking. Feedback handling is excellent at 4.8/5, slightly above the category average, indicating stable performance during typical daily activities. However, speech-in-noise performance is notably limited, scoring just 1.1/5—0.82 points below the category average of 1.96. This is a meaningful weakness for users who frequently encounter noisy environments like restaurants or social gatherings. Speech in quiet is solid at 3.2/5, though slightly below the category average. Music streaming scores 2.8/5, above average but only mixed in absolute terms. At this price point, buyers should consider alternatives. The Rexton Reach R-Li T80 at Costco scores 4.58/5 in the same price range, while lower-priced options like the Lexie B3 (4.76/5) offer stronger overall performance. The Jabra Enhance Pro 20 may suit users who prioritize own-voice comfort and feedback stability over challenging listening environments, but those needing robust noise handling should explore other options.

The Resound Vivia 9 60S microRIE is a premium prescription behind-the-ear hearing aid released in 2025, currently available at $3,798. In HearAdvisor's lab testing, it earned a B grade with a SoundScore of 3.9/5, ranking #27 of 36 prescription hearing aids tested. This device demonstrates a mixed performance profile in our testing. Own-voice comfort is a notable strength, scoring 3.4/5—a solid result that sits 0.65 points above the category average, which may appeal to users sensitive to the hollow or boomy sound of their own speech. Speech clarity in quiet environments also performs well at 3.4/5, slightly above the category average. However, the Vivia 9 shows significant limitations in challenging listening situations. Speech in noise scored just 1.1/5, falling 0.81 points below the prescription hearing aid average—a substantial gap that suggests difficulty in restaurants, group conversations, or other noisy environments. Feedback handling, while strong in absolute terms at 4.2/5, still lands 0.51 points below what we typically see from prescription devices. Music streaming quality is mixed at 2.6/5, essentially matching the category average. At this premium price point, the Vivia 9 faces stiff competition. Several same-priced alternatives, including the Phonak Sphere Infinio and Oticon Intent, achieved notably higher overall scores in our testing. Consumers prioritizing noise performance may want to explore these options or consider lower-priced alternatives like the Sennheiser All Day Clear that delivered stronger overall results in our lab.